# Lynn Silver, MD, MPH, FAAP, Highlights Psychiatric Risks of Adolescent Cannabis Exposure > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/adolescent-cannabis-exposure-psychiatric-risks/ > **Published:** 2026-02-26T18:16:31-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:13:45-04:00 > **Clinical Summary:** Explore adolescent cannabis exposure psychiatric risks and their impact on mental health during critical brain development stages. ---   ✦ New CED Clinical Relevance**#78 Strong Clinical RelevanceHigh-quality evidence with meaningful patient or clinical significance. PediatricsMental HealthTHCSafetyResearch Why This MattersParents and young people should understand that [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) during adolescence is not a low-stakes decision, because the developing brain processes cannabinoids very differently than an adult brain does, with potential consequences for long-term mental health. Clinical Summary [Adolescent cannabis use](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) carries meaningful psychiatric risks because the developing brain, particularly the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/), is uniquely vulnerable to disruption from exogenous cannabinoids during the years of active neurodevelopment that extend into the mid-twenties. Exposure during this window has been associated with increased rates of anxiety, depression, and psychosis, with higher-potency THC products amplifying these concerns considerably. Clinicians working with young patients and their families need to communicate these risks clearly, since the cultural normalization of cannabis has outpaced public understanding of its developmental consequences. Dr. Caplan’s Take“We cannot keep treating adolescent cannabis exposure as a social footnote while the potency of available products has increased by orders of magnitude over the past two decades.” Clinical Perspective Dr. Silver raises important considerations about adolescent cannabis exposure during critical neurodevelopmental windows. The endocannabinoid system’s role in brain maturation means timing of exposure matters significantly for long-term psychiatric outcomes. While cannabis has legitimate therapeutic applications in adult populations, the evidence increasingly suggests adolescent use carries distinct risks that warrant cautious, individualized assessment. ️ Clinicians should engage families in conversations about these developmental vulnerabilities when discussing cannabis in younger patients. Age-appropriate risk stratification remains essential to responsible [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) practice. Want the full critical read? Dr Caplan’s review of the JAMA Health Forum paper, including what the methods do and do not allow us to conclude: [Adolescent Cannabis Use and Psychosis Risk – Study Review](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/)   💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Lynn+Silver%2C+MD%2C+MPH%2C+FAAP%2C+warns+of+psychiatric+risks+with+adolescent+cannabis+use+%40drcaplan&url=https%3A%2F%2Fwww.contemporarypediatrics.com%2Fview%2Flynn-silver-md-mph-faap-warns-of-psychiatric-risks-with-adolescent-cannabis-use) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.contemporarypediatrics.com%2Fview%2Flynn-silver-md-mph-faap-warns-of-psychiatric-risks-with-adolescent-cannabis-use) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Lynn+Silver%2C+MD%2C+MPH%2C+FAAP%2C+warns+of+psychiatric+risks+with+adolescent+cannabis+use+%E2%80%94+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.contemporarypediatrics.com%2Fview%2Flynn-silver-md-mph-faap-warns-of-psychiatric-risks-with-adolescent-cannabis-use) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - Lynn Silver, MD, MPH, FAAP, warns of psychiatric risks with adolescent cannabis** use 📰 Source: [https://www.contemporarypediatrics.com/view/lynn-silver-md-mph-faap-warns-of-psychiatric-risks-with-adolescent-cannabis-use](https://www.contemporarypediatrics.com/view/lynn-silver-md-mph-faap-warns-of-psychiatric-risks-with-adolescent-cannabis-use) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Teen Cannabis Use May Double Your Risk of Psychosis and Bipolar](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) This article explores the increased risks of psychosis and [bipolar disorder](https://cedclinic.com/cannabis-induced-appetite-satiety-bypass-thc-brain/) linked to teen [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/), providing valuable context for adolescent psychiatric risks. [Read More](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) [Teen Marijuana Use Doubles Chances of Future Psychotic Disorders, Study Finds](https://cedclinic.com/adolescent-cannabis-use-psychotic-risk-study/) A study highlighting the doubled risk of psychotic disorders in teens who use marijuana, reinforcing concerns about adolescent cannabis exposure. [Learn More](https://cedclinic.com/adolescent-cannabis-use-psychotic-risk-study/) [Kaiser Study Finds Higher Risk of Psychiatric Disorders in Teens Who Reported Cannabis Use](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) This Kaiser study provides evidence of increased psychiatric disorder risks among teens reporting cannabis use, supporting clinical caution. [Explore Study](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).